Biosimilar insulins in international and domestic practice of pharmacist
In Ukraine, people with diabetes receive insulin, including insulin biosimilars in pharmacies, so pharmacists should increase their knowledge about biosimilar because they become more available in the coming years. The aim of the work was to summarize current information on insulin biosimilars. Rese...
Saved in:
Main Authors: | I. O. Vlasenko (Author), I. V. Nizhenkovska (Author) |
---|---|
Format: | Book |
Published: |
The State Expert Center of the Ministry of Health of Ukraine,
2022-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of Russian insulin biosimilars for type 1 diabetes in adolescents
by: V.V. Platonov, et al.
Published: (2022) -
Biosimilar medicines uptake: The role of the clinical pharmacist
by: Roland Nnaemeka Okoro
Published: (2021) -
Knowledge and Perception of Iraqi Pharmacists Towards Biosimilar Medicines
by: Ashwaq J. Mohammed, et al.
Published: (2021) -
Pharmaceutical care for patients with diabetes: storage of insulin
by: I. O. Vlasenko, et al.
Published: (2019) -
Considerations for the US health-system pharmacist in a world of biosimilars
by: Andrea Zlatkus, et al.
Published: (2020)